These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Tumorous variant of scleromyxedema. Successful therapy with intravenous immunoglobulins. Wojas-Pelc A; Błaszczyk M; Glińska M; Jabłońska S J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):462-5. PubMed ID: 15987294 [TBL] [Abstract][Full Text] [Related]
11. [Results of high-dose intravenous immunoglobulin treatment of patients with pretibial myxedema and Basedow's disease. Preliminary findings]. Antonelli A; Saracino A; Agostini S; Alberti B; Melosi A; Gambuzza C; Avantaggiato G; Baschieri L Clin Ter; 1992 Sep; 141(9 Pt 2):63-8. PubMed ID: 1281765 [TBL] [Abstract][Full Text] [Related]
12. Scleromyxoedema-like changes in four renal dialysis patients. Hubbard V; Davenport A; Jarmulowicz M; Rustin M Br J Dermatol; 2003 Mar; 148(3):563-8. PubMed ID: 12653751 [TBL] [Abstract][Full Text] [Related]
13. [Internal disease findings in Arndt-Gottron scleromyxedema]. Lang E; Goos M Dtsch Med Wochenschr; 1986 May; 111(21):820-3. PubMed ID: 3084193 [TBL] [Abstract][Full Text] [Related]
14. Scleromyxoedema: clinical follow-up after successful treatment with high-dose immunoglobulins reveals different long-term outcomes. Bidier M; Zschoche C; Gholam P; Enk AH; Hadaschik EN Acta Derm Venereol; 2012 Jul; 92(4):408-9. PubMed ID: 22278389 [No Abstract] [Full Text] [Related]
15. Arndt-Gottron scleromyxoedema: successful therapy with intravenous immunoglobulins. Gholam P; Hartmann M; Enk A Br J Dermatol; 2007 Nov; 157(5):1058-60. PubMed ID: 17854360 [No Abstract] [Full Text] [Related]
16. Dermato-neuro syndrome after COVID-19 infection in a patient with scleromyxoedema: Previously successful treatment with intravenous immunoglobulins. Li Y; Wang H; Wang A; Zhao G J Dermatol; 2024 Jan; 51(1):140-144. PubMed ID: 37830263 [TBL] [Abstract][Full Text] [Related]